These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3391372)

  • 1. Features reflective of early prognosis in corticosteroid-treated severe autoimmune chronic active hepatitis.
    Czaja AJ; Rakela J; Ludwig J
    Gastroenterology; 1988 Aug; 95(2):448-53. PubMed ID: 3391372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical features and prognostic implications of severe corticosteroid-treated cryptogenic chronic active hepatitis.
    Czaja AJ; Hay JE; Rakela J
    Mayo Clin Proc; 1990 Jan; 65(1):23-30. PubMed ID: 2296210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The nature and prognosis of severe cryptogenic chronic active hepatitis.
    Czaja AJ; Carpenter HA; Santrach PJ; Moore SB; Homburger HA
    Gastroenterology; 1993 Jun; 104(6):1755-61. PubMed ID: 8500735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and prognosis of histologic cirrhosis in corticosteroid-treated hepatitis B surface antigen-negative chronic active hepatitis.
    Davis GL; Czaja AJ; Ludwig J
    Gastroenterology; 1984 Dec; 87(6):1222-7. PubMed ID: 6489694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoimmune features as determinants of prognosis in steroid-treated chronic active hepatitis of uncertain etiology.
    Czaja AJ; Davis GL; Ludwig J; Baggenstoss AH; Taswell HF
    Gastroenterology; 1983 Sep; 85(3):713-7. PubMed ID: 6192038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and prognostic implications of HLA B8 in corticosteroid-treated severe autoimmune chronic active hepatitis.
    Czaja AJ; Rakela J; Hay JE; Moore SB
    Gastroenterology; 1990 Jun; 98(6):1587-93. PubMed ID: 2338197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency and significance of antibody to hepatitis C virus in severe corticosteroid-treated autoimmune chronic active hepatitis.
    Czaja AJ; Taswell HF; Rakela J; Schimek CM
    Mayo Clin Proc; 1991 Jun; 66(6):572-82. PubMed ID: 1646353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency and significance of antibody to hepatitis C virus in severe corticosteroid-treated cryptogenic chronic active hepatitis.
    Czaja AJ; Taswell HF; Rakela J; Schimek CM
    Mayo Clin Proc; 1990 Oct; 65(10):1303-13. PubMed ID: 2170781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclosporine in the management of corticosteroid-resistant type I autoimmune chronic active hepatitis.
    Sherman KE; Narkewicz M; Pinto PC
    J Hepatol; 1994 Dec; 21(6):1040-7. PubMed ID: 7699225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corticosteroid-treated chronic active hepatitis in remission: uncertain prognosis of chronic persistent hepatitis.
    Czaja AJ; Ludwig J; Baggenstoss AH; Wolf A
    N Engl J Med; 1981 Jan; 304(1):5-9. PubMed ID: 7432437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained remission after corticosteroid therapy of severe hepatitis B surface antigen-negative chronic active hepatitis.
    Czaja AJ; Beaver SJ; Shiels MT
    Gastroenterology; 1987 Jan; 92(1):215-9. PubMed ID: 3781190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic features and role of liver transplantation in severe corticosteroid-treated autoimmune chronic active hepatitis.
    Sanchez-Urdazpal L; Czaja AJ; van Hoek B; Krom RA; Wiesner RH
    Hepatology; 1992 Feb; 15(2):215-21. PubMed ID: 1735524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exquisite sensitivity to small decrements in corticosteroid dose in autoimmune chronic active hepatitis.
    Runyon BA
    J Clin Gastroenterol; 1987 Oct; 9(5):541-2. PubMed ID: 3680903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B virus deoxyribonucleic acid in serum during hepatitis B e antigen clearance in corticosteroid-treated severe chronic active hepatitis B.
    Wood JR; Czaja AJ; Taswell HF; Ludwig J; Rakela J; Chase R
    Gastroenterology; 1987 Dec; 93(6):1225-30. PubMed ID: 3678739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic hepatitis with combined features of autoimmune chronic hepatitis and chronic hepatitis C: favorable response to prednisone and azathioprine.
    Bellary S; Schiano T; Hartman G; Black M
    Ann Intern Med; 1995 Jul; 123(1):32-4. PubMed ID: 7762911
    [No Abstract]   [Full Text] [Related]  

  • 16. Prognosis of corticosteroid-treated hepatitis B surface antigen-negative chronic active hepatitis in postmenopausal women: a retrospective analysis.
    Wang KK; Czaja AJ
    Gastroenterology; 1989 Nov; 97(5):1288-93. PubMed ID: 2792661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclosporine treatment of autoimmune chronic active hepatitis.
    Hyams JS; Ballow M; Leichtner AM
    Gastroenterology; 1987 Oct; 93(4):890-3. PubMed ID: 2887482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pregnancy in chronic active hepatitis with cirrhosis.
    Lee MG; Hanchard B; Donaldson EK; Charles C; Hall JS
    J Trop Med Hyg; 1987 Oct; 90(5):245-8. PubMed ID: 3669126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of autoimmune chronic active hepatitis in childhood.
    Maggiore G; Bernard O; Hadchouel M; Hadchouel P; Odievre M; Alagille D
    J Pediatr; 1984 Jun; 104(6):839-44. PubMed ID: 6726513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-induced chronic active hepatitis?
    Silva MO; Reddy KR; Jeffers LJ; Hill M; Schiff ER
    Gastroenterology; 1991 Sep; 101(3):840-2. PubMed ID: 1860646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.